We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NEW DEADLINE FOR OBTAINING FDA APPROVAL FOR DIGOXIN ELIXIRS
NEW DEADLINE FOR OBTAINING FDA APPROVAL FOR DIGOXIN ELIXIRS
June 28, 2004
Manufacturers of digoxin elixirs can continue marketing them without agency-approved new drug applications for an additional six months to ensure continued availability of the products, the FDA announced.